Intrarosa

Prasterone, the active ingredient in Intrarosa, is an androgen (dehydroepiandrosterone, DHEA) presented as a vaginal insert for vaginal use. It is indicated for the treatment of dyspareunia associated with vulvar and vaginal atrophy in postmenopausal women, helping to restore vaginal tissue health and lubrication.

GNH USA supplies Intrarosa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for this prescription‑only product while adhering to stringent quality standards and offering regulatory support for global distribution.

Intrarosa, a vaginal DHEA therapy, is used to address conditions related to postmenopausal vulvovaginal atrophy.

Vulvar atrophy: improves tissue health and reduces thinning of the vulvar epithelium. Vaginal dryness: enhances natural lubrication and moisture levels. Dyspareunia: lessens pain during sexual intercourse associated with atrophic changes.

Intrarosa may cause local and systemic adverse reactions.

Common Side Effects: - Vaginal irritation or burning sensation. - Increased vaginal discharge or spotting. - Itching or mild rash in the genital area. - Unpleasant odor from the insert. - Mild abdominal discomfort. - Headache.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling or difficulty breathing. - Significant vulvar edema or swelling. - Persistent vaginal bleeding. - Hormone‑related systemic effects such as hirsutism. - Unexplained weight gain or mood changes. - Signs of infection at the insertion site.

Before prescribing Intrarosa, clinicians should consider several safety aspects.

Assess contraindications: verify absence of known hypersensitivity to prasterone or excipients. Monitor for irritation: advise patients to report persistent burning or severe discomfort. Evaluate hormonal status: consider potential interactions with systemic hormone therapies. Avoid use in active genital infections: ensure infections are treated prior to initiation. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Intrarosa can interact with other medications that affect hormonal pathways or vaginal environment.

Major Interactions (Avoid): - Systemic estrogen or androgen therapy: additive hormonal effects may increase risk of side effects. - Strong CYP3A4 inducers (e.g., rifampin): may reduce local conversion of DHEA to active hormones.

Moderate Interactions (Monitor Closely): - Antifungal vaginal agents (e.g., clotrimazole): may alter local absorption. - Antimicrobial vaginal gels or spermicides: monitor for increased irritation. - Oral contraceptives containing estrogen: observe for potential hormonal imbalance.